Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Aditxt, Inc. amended Second Amendment to Merger Agreement with Adicure, Inc. and Evofem Biosciences, Inc. (effective 2024-01-30).
- Action
- amendment
- Agreement
- merger
- Counterparty
- Adicure, Inc. and Evofem Biosciences, Inc.
- Effective
- 2024-01-30
Exact text from the filing
On January 30, 2024, the Company, Adicure and Evofem entered into the Second Amendment to the Merger Agreement (the “ Second Amendment to Merger Agreement ”) to amend (i) the date of the Parent Loan (as defined in the Merger Agreement) to Evofem to be February 29, 2024, (ii) to change the date by which Evofem may terminate the Merger Agreement for failure to receive the Parent Loan to be February 29, 2024, and (iii) to change the filing date for the Joint Proxy Statement (as defined in the Merger Agreement) to April 1, 2024.
View on SEC.gov